4DMedical Raises AU$8.4 Million via Oversubscribed Share Purchase Plan; Shares Two-Year Low

MT Newswires Live

Mar 25, 2025

4DMedical (ASX:4DX) raised AU$8.4 million via its oversubscribed share purchase plan, according to a Tuesday filing with the Australian bourse.

The company exercised its discretion not to scale back the AU$1.4 million in oversubscription.

New shares are priced at AU$0.36 apiece, a 2.5% discount to the five-day volume-weighted average of the company's shares.

More than 23.3 million new shares will be allotted on Tuesday and are expected to start trading on Wednesday.

In total, the company raised AU$13.9 million via an earlier placement and the share purchase plan. This will be used for general working capital amid a push to advance the commercialization of the company's lung diagnostics portfolio and support the Food and Drug Administration approval of its ventilation and perfusion technology, the filing stated.

The respiratory imaging technology company's shares were up over 1% in recent Tuesday trade, earlier hitting their lowest since March 2023.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2522558570"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2522558570\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2522558570?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-25 10:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2522558570","market":"sh","top_or_hot":-1,"title":"4DMedical Raises AU$8.4 Million via Oversubscribed Share Purchase Plan; Shares Two-Year Low","media":"MT Newswires Live","content":"<html><body><p> 4DMedical (ASX:4DX) raised AU$8.4 million via its oversubscribed share purchase plan, according to a Tuesday filing with the Australian bourse.</p><p>The company exercised its discretion not to scale back the AU$1.4 million in oversubscription.</p><p>New shares are priced at AU$0.36 apiece, a 2.5% discount to the five-day volume-weighted average of the company's shares.</p><p>More than 23.3 million new shares will be allotted on Tuesday and are expected to start trading on Wednesday.</p><p>In total, the company raised AU$13.9 million via an earlier placement and the share purchase plan. This will be used for general working capital amid a push to advance the commercialization of the company's lung diagnostics portfolio and support the Food and Drug Administration approval of its ventilation and perfusion technology, the filing stated.</p><p>The respiratory imaging technology company's shares were up over 1% in recent Tuesday trade, earlier hitting their lowest since March 2023.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4DMedical Raises AU$8.4 Million via Oversubscribed Share Purchase Plan; Shares Two-Year Low</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4DMedical Raises AU$8.4 Million via Oversubscribed Share Purchase Plan; Shares Two-Year Low\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-03-25 10:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> 4DMedical (ASX:4DX) raised AU$8.4 million via its oversubscribed share purchase plan, according to a Tuesday filing with the Australian bourse.</p><p>The company exercised its discretion not to scale back the AU$1.4 million in oversubscription.</p><p>New shares are priced at AU$0.36 apiece, a 2.5% discount to the five-day volume-weighted average of the company's shares.</p><p>More than 23.3 million new shares will be allotted on Tuesday and are expected to start trading on Wednesday.</p><p>In total, the company raised AU$13.9 million via an earlier placement and the share purchase plan. This will be used for general working capital amid a push to advance the commercialization of the company's lung diagnostics portfolio and support the Food and Drug Administration approval of its ventilation and perfusion technology, the filing stated.</p><p>The respiratory imaging technology company's shares were up over 1% in recent Tuesday trade, earlier hitting their lowest since March 2023.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7094","symbol_name":"医疗保健技术","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2522558570","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2522558570","pubTimestamp":1742871392,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"4DMedical (ASX:4DX) raised AU$8.4 million via its oversubscribed share purchase plan, according to a Tuesday filing with the Australian bourse.The company exercised its discretion not to scale back th","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7094":"医疗保健技术","4DX.AU":"4DMEDICAL LTD"},"translate_title":"4DMedical通过超额认购股票购买计划筹集840万澳元；股价创两年新低","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"4DX.AU":0.9},"content_text":"4DMedical (ASX:4DX) raised AU$8.4 million via its oversubscribed share purchase plan, according to a Tuesday filing with the Australian bourse.The company exercised its discretion not to scale back the AU$1.4 million in oversubscription.New shares are priced at AU$0.36 apiece, a 2.5% discount to the five-day volume-weighted average of the company's shares.More than 23.3 million new shares will be allotted on Tuesday and are expected to start trading on Wednesday.In total, the company raised AU$13.9 million via an earlier placement and the share purchase plan. This will be used for general working capital amid a push to advance the commercialization of the company's lung diagnostics portfolio and support the Food and Drug Administration approval of its ventilation and perfusion technology, the filing stated.The respiratory imaging technology company's shares were up over 1% in recent Tuesday trade, earlier hitting their lowest since March 2023.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}